The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure
EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
May 31, 2005
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Conditions
Heart Failure
Interventions
DRUG
Simvastatin
Simvastatin 40 mg tablet
Trial Locations (1)
84112
University of Utah, Salt Lake City
All Listed Sponsors
lead
University of Utah
OTHER
NCT00769210 - The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure | Biotech Hunter | Biotech Hunter